D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
PUT
Applied Materials
AMAT
$426B
| $40.8M | 0.05% |
882,400
+452,300
| +105% | +$23.3M |
|
|
ENDP
427
DELISTED
Endo International plc
ENDP
| $40.7M | 0.05% |
4,318,896
+833,495
| +24% | +$5.6M |
|
428
United Therapeutics
UTHR
$26.3B
| $40.7M | 0.05% |
359,920
-52,272
| -13% | -$5.75M |
|
|
FNGN
429
DELISTED
Financial Engines, Inc.
FNGN
| $40.7M | 0.05% |
907,007
-304,641
| -25% | -$12.6M |
|
430
Bloomin' Brands
BLMN
$680M
| $40.4M | 0.05% |
2,009,329
+828,664
| +70% | +$18.8M |
|
431
LiveRamp
RAMP
$2.29B
| $40.2M | 0.05% |
1,341,289
+292,512
| +28% | +$8.01M |
|
432
Zimmer Biomet
ZBH
$17.7B
| $40.1M | 0.05% |
370,884
+61,065
| +20% | +$6.65M |
|
433
Melco Resorts & Entertainment
MLCO
$2.1B
| $40.1M | 0.05% |
1,432,961
+708,762
| +98% | +$21.7M |
|
434
Trane Technologies
TT
$106B
| $40.1M | 0.05% |
446,600
-137,521
| -24% | -$12.1M |
|
435
Williams Companies
WMB
$90.5B
| $39.8M | 0.05% |
1,468,315
-427,076
| -23% | -$11.3M |
|
436
Pediatrix Medical
MD
$2.16B
| $39.5M | 0.05% |
913,672
+595,958
| +188% | +$28.6M |
|
|
437
PUT
Bristol-Myers Squibb
BMY
$127B
| $39.4M | 0.05% |
712,600
+322,600
| +83% | +$17.4M |
|
438
Cenovus Energy
CVE
$54.6B
| $39.4M | 0.05% |
+3,795,054
| New | +$38.2M |
|
|
EQC
439
DELISTED
Equity Commonwealth
EQC
| $39.4M | 0.05% |
1,249,584
-250,004
| -17% | -$7.73M |
|
|
PRSP
440
DELISTED
Perspecta Inc. Common Stock
PRSP
| $39.3M | 0.05% |
+1,914,792
| New | +$42.9M |
|
441
NCR Voyix
VYX
$1.06B
| $38.7M | 0.05% |
2,106,120
-20,391
| -1% | -$385K |
|
|
CMA
442
DELISTED
Comerica
CMA
| $38.2M | 0.05% |
419,998
-85,699
| -17% | -$8.21M |
|
443
Ares Capital
ARCC
$13.5B
| $37.8M | 0.05% |
2,300,241
+1,079,252
| +88% | +$17.7M |
|
444
Jacobs Solutions
J
$15.9B
| $37.7M | 0.05% |
717,046
-232,043
| -24% | -$11.9M |
|
445
Lockheed Martin
LMT
$134B
| $37.7M | 0.05% |
127,466
-33,652
| -21% | -$10.9M |
|
446
Equifax
EFX
$20.3B
| $37.4M | 0.05% |
298,625
-761,953
| -72% | -$90.3M |
|
|
ZEN
447
DELISTED
ZENDESK INC
ZEN
| $37.3M | 0.05% |
683,799
+478,219
| +233% | +$25.4M |
|
|
MDRX
448
DELISTED
Veradigm Inc. Common Stock
MDRX
| $37.1M | 0.05% |
3,091,113
+39,366
| +1% | +$485K |
|
449
Zebra Technologies
ZBRA
$12.4B
| $37.1M | 0.05% |
258,718
-27,720
| -10% | -$4.08M |
|
450
MGM Resorts International
MGM
$11.7B
| $37M | 0.05% |
1,275,732
-1,345,175
| -51% | -$43.4M |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.